Nate Spangler, Ph.D., Director of Innovation & Strategy, outlines the capability of Aldevron mRNA production. Joining him are Tom Lynch, Ph.D., VP of Client Services for Proteins, and James Sulzberger, Technical Director of Client Services for Proteins, who will discuss capabilities for supplying enzymes for RNA manufacturing and other proteins for vaccine development.